Center-Authored Papers

Filters: Author is Børresen-Dale, Anne-Lise  [Clear All Filters]
Journal Article
Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, Shu X-O, Schmidt MK, Milne RL et al..  2016.  Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry.. Cancer causes & control : CCC. 27(5):679-693. Abstract
Borg A, Haile RW, Malone KE, Capanu M, Diep A, Törngren T, Teraoka S, Begg CB, Thomas DC, Concannon P et al..  2010.  Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.. Human mutation. 31(3):E1200-40. Abstract
Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FBL, Bueno-de-Mesquit BH et al..  2012.  Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).. PloS one. 7(8):e42380. Abstract
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK et al..  2016.  Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.. Nature communications. 7:12675. Abstract
Guo Y, Warren Andersen S, Shu X-O, Michailidou K, Bolla MK, Wang Q, Garcia-Closas M, Milne RL, Schmidt MK, Chang-Claude J et al..  2016.  Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent.. PLoS medicine. 13(8):e1002105. Abstract
Bilal E, Dutkowski J, Guinney J, Jang IS, Logsdon BA, Pandey G, Sauerwine BA, Shimoni Y, Moen Vollan HK, Mecham BH et al..  2013.  Improving breast cancer survival analysis through competition-based multidimensional modeling.. PLoS computational biology. 9(5):e1003047. Abstract
Figueiredo JC, Haile RW, Bernstein L, Malone KE, Largent J, Langholz B, Lynch CF, Bertelsen L, Capanu M, Concannon P et al..  2010.  Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study.. Breast cancer research and treatment. 120(1):175-83. Abstract
Concannon P, Haile RW, Børresen-Dale A-L, Rosenstein BS, Gatti RA, Teraoka SN, Diep AT, Jansen L, Atencio DP, Langholz B et al..  2008.  Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.. Cancer research. 68(16):6486-91. Abstract